# Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

> **NCT01060787** · — · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 98 (actual)

## Conditions studied

- Inflammation
- Uveitis

## Interventions

- **PROCEDURE:** Fluocinolone Acetonide 0.59 mg
- **PROCEDURE:** Fluocinolone Acetonide 2.1 mg

## Key facts

- **NCT ID:** NCT01060787
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-04
- **Primary completion:** 2019-03-07
- **Final completion:** 2019-06-07
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060787, "Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01060787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*